Real-time enrollment status for this systemic sclerosis clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 2:46 AM UTC
| NCT Number | NCT07047690 |
| Recruiting Status | Recruiting |
| Condition | Systemic Sclerosis |
| Phase | PHASE2 |
| Target Enrollment | 162 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Galderma R&D |
| Last Updated on CT.gov | March 31, 2026 (Mar 31, 2026) |
As of August 29, 2026: Clinical trial NCT07047690 is currently recruiting participants. This phase2 study for systemic sclerosis is actively seeking new participants at 2 locations across the United States. The study is sponsored by Galderma R&D. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07047690 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07047690 was last updated Mar 31, 2026 (March 31, 2026). HelloStudys verifies this status automatically.